MarketCatalyst
← Back to Resources
Earnings

Nebius Beats Q3 2026 Estimates as Revenue Rises 571% to $980.8M

Revenue of $980.8M vs. $907.2M expected and adjusted EPS of $0.30 vs. -$0.72; revenue up 571% from a year earlier.

Published Nov 12, 2026 · 9:32 AM ET · 2 min read

Nebius (NBIS) beat estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $980.8 million, up 571% from a year earlier, above the $907.2 million estimate, and adjusted EPS was $0.30 above the -$0.72 estimate.

Shares fell 20% in regular trading as of 9:33 a.m. ET, at $123.23.

$0.30
Adjusted EPS vs. -$0.72 estimate
$980.8M
Revenue, up 571% YoY vs. $907.2M estimate
-20%
Shares in regular trading as of 9:33 a.m. ET

Q3 2026 scorecard

ParametersExpectedActualBeat/Miss
Adjusted EPS-$0.72$0.30Beat by 141%
Revenue$907.2M$980.8MBeat by 8.1%
ChangeYoYQoQ
Adjusted EPS▲ from -$0.39▲ from -$0.12
Revenue▲ 571%▲ 68%

By our calculation, revenue was $73.6 million above the estimate and adjusted EPS was $1.02 above it. The QoQ column compares with the previous quarter's revenue of $582.3 million and adjusted EPS of -$0.12. The YoY column compares with $146.1 million and -$0.39 in the same quarter a year earlier.

Track record

  • EPS record. Adjusted EPS beat the estimate in 6 of the last 8 reports, including this one.
  • Revenue record. Revenue beat the estimate in 3 of the last 8 reports.
  • Revenue trend. Revenue over the last 5 reports, oldest first: $146.1 million, $227.7 million, $399.0 million, $582.3 million and $980.8 million.

What to watch

  • Next-quarter estimates. Consensus calls for EPS of -$0.81 and revenue of $1.46 billion next quarter, based on 4 analysts.
  • Next report. Nebius is next expected to report on Feb. 11, 2027.
  • Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 571% increase to $980.8 million.
  • Related coverage. See our reports on Parabilis Medicines, Hudbay Minerals, Accelerant and Ondas.

Sources: Results are from Nebius's Nov. 12, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Nebius's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.

Readers also read

MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.

Nebius Beats Q3 2026 Estimates